Moreover, TLR9-mediated tumor progression involves the implication of various chemokines, particularly CCL2 and CCL5, along with matrix metalloproteinases (MMP), such as MMP-2 and MMP-9 [44,45,46]. The gene discussed is CCL2; the disease is neoplasm.